Clinical trial · Interventional
Using Community Health Navigators to Advance Cancer Screening Adherence
Using Community Health Navigators to Advance Cancer Screening Adherence Through Videoconferencing for All Americans Who Use ASL: A Randomized Controlled Trial Study
NCT06492993CI-TRIAL-00107170completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Intervention to promote cancer screenings among deaf, deafblind, and hard of hearing participants who have not received screening within the recommended guideline.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Deafness | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Education | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- CHN provides educational sessions with patients at time points.
- interventionNames
- Other: Education
- type
- NO_INTERVENTION
- label
- Standard of Care
- description
- Standard of care to inform participant about the screening recommendations and check ins.
Primary outcomes (1)
- measure
- Number of participants who are adherent to cancer screening
- timeFrame
- 9 months
- description
- Completion of at least one recommended cancer screening as measured by documentation of the actual screening
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 45 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Provision of signed and dated informed consent form Stated willingness to comply with all study procedures and lifestyle considerations (see Section 5.3, Lifestyle Considerations) and availability for the duration of the study Male or female at birth age 45-80yo or female at birth age 45-80yo; age-eligible according to screening criteria Self-reported diagnosis of bilateral hearing loss at birth or prior to 13 years old (defined as "early deafness") and use ASL Willingness to adhere to the CHN clinical trial regimen Willingness to provide cancer screening verification documentation; this will be reviewed during the informed consent procedure Access to necessary resources to support video-based communication Non-adherent to one or more cancer screening guidelines for breast, lung, prostate, colon, cervical cancers will be those who reported not having had the appropriate recommended screenings within the past year to cancer screening questions in the HINTS-ASL survey Exclusion Criteria: * Presence of full ability to hear in one or both ears beyond 13 years of age Younger or older than the age cutoff for the recommended cancer screening Not capable of independently conducting the activities of daily living In compliance with age- or risk-specific screening at the time of evaluation for study eligibility Are currently undergoing cancer treatment or being evaluated for the presence of cancer at the time of evaluation for study eligibility Will be engaged in more than 21 consecutive days of travel during the eleven-month study window Knows other participants at baseline
References
Publications (1)
- DERIVEDKushalnagar P, Rao SR, Bergeron E, Valdez R, Wang R, Kushalnagar RS, Sadler GR. Using American Sign Language-Fluent Community Health Navigators to Advance Cancer Screening Adherence through Videoconferencing With Deaf, Deafblind, and Hard of Hearing Adults: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Sep 9;14:e65078. doi: 10.2196/65078. PMID 40925603